301235 华康医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.6166.3019.13114.75610.860
总资产报酬率 ROA (%)-0.3674.0825.6827.6926.298
投入资产回报率 ROIC (%)-0.4234.8817.1259.6218.331

边际利润分析
销售毛利率 (%)36.62738.03938.26937.25533.078
营业利润率 (%)-2.6667.6679.62110.7567.818
息税前利润/营业总收入 (%)-0.9118.0399.85411.9648.658
净利润/营业总收入 (%)-1.9446.7028.6209.4526.905

收益指标分析
经营活动净收益/利润总额(%)-2.020156.184130.908127.935155.874
价值变动净收益/利润总额(%)-0.1775.1507.5500.0000.000
营业外收支净额/利润总额(%)0.720-1.4242.6102.138-1.956

偿债能力分析
流动比率 (X)1.9671.9473.0901.8502.271
速动比率 (X)1.6221.6942.7051.6071.926
资产负债率 (%)41.59139.32130.21652.2060.417
带息债务/全部投入资本 (%)31.23327.39812.26736.34127.543
股东权益/带息债务 (%)213.835257.561704.410168.974255.015
股东权益/负债合计 (%)140.439154.319230.95091.550139.546
利息保障倍数 (X)-0.51316.759-390.94112.2958.742

营运能力分析
应收账款周转天数 (天)452.156278.079269.947240.576232.317
存货周转天数 (天)167.78398.070101.93890.13987.548